Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // August 4th, 2011 // 7:04 am
Hello, everyone, and how are you today? Another balmy day appears to be in store for those of us on the Pharmalot corporate campus, but we plan to stay cool with a hot cup or three of stimulation. Of course, we invite you to join us. Meanwhile, we have foraged once again for some interesting items from around the world. So here you go. Have a great day and stay in touch…
Pharma Cargo Thefts Drop In First Half Of 2011 (Securing Pharma)
Medtronic Hires Yale Researcher To Review Infuse Safety (Milwaukee Journal-Sentinel)
Joint API Plant Inspection Program May Go Global (InPharma Technologist)
FDA Says High Doses Of Fluconazole Might Cause Birth Defects (Dow Jones)
Novo Nordisk Faces Slow Growth In Newer Insulin Sales (Reuters)
Pfizer Pulls Out Of Deal With Biotica (Pharma Times)
Roche Asthma Drug Shows Promise In Mid-Stage Trials (Reuters)
EDITOR’S NOTE: Please check this post for updates throughout the morning
Coffee pix thx to chichcacha on flickr creative commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Active Pharmaceutical Ingredient, API, Biotica, Birth Defects, Dendreon, Diflucan, FDA, Fluconazole, Infuse, Insulin, Medtronic, Novo Nordisk, Pfizer, Provenge, Roche, Victoza